Zegeng Li

741 total citations
49 papers, 524 citations indexed

About

Zegeng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine. According to data from OpenAlex, Zegeng Li has authored 49 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Complementary and alternative medicine. Recurrent topics in Zegeng Li's work include Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Zegeng Li is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Zegeng Li collaborates with scholars based in China, Macao and United States. Zegeng Li's co-authors include Huan Wu, Jie Zhu, Lei Gan, Yang Chen, Xinheng Wang, Dianlei Wang, Yating Gao, Chen Yang, Xingxing Zhang and Xianhua Liu and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Expert Systems with Applications.

In The Last Decade

Zegeng Li

42 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zegeng Li China 14 282 111 90 58 57 49 524
Varsha Rana India 12 350 1.2× 52 0.5× 53 0.6× 43 0.7× 103 1.8× 15 692
Gang Fang China 14 233 0.8× 35 0.3× 73 0.8× 36 0.6× 50 0.9× 41 697
Thikryat Neamatallah Saudi Arabia 18 301 1.1× 34 0.3× 47 0.5× 55 0.9× 65 1.1× 41 865
Kuppannan Gobianand India 13 264 0.9× 108 1.0× 67 0.7× 38 0.7× 87 1.5× 18 742
Riyad A. Almaimani Saudi Arabia 16 208 0.7× 45 0.4× 65 0.7× 102 1.8× 52 0.9× 51 730
Yaxiong Tang China 15 436 1.5× 92 0.8× 64 0.7× 32 0.6× 117 2.1× 42 775
Sheik Aliya South Korea 14 288 1.0× 34 0.3× 51 0.6× 58 1.0× 118 2.1× 27 627
Junping Kou China 11 266 0.9× 44 0.4× 47 0.5× 22 0.4× 69 1.2× 16 490
Atif Abdulwahab A. Oyouni Saudi Arabia 16 167 0.6× 26 0.2× 54 0.6× 46 0.8× 52 0.9× 54 666
Huagang Liu China 16 277 1.0× 83 0.7× 37 0.4× 31 0.5× 76 1.3× 42 661

Countries citing papers authored by Zegeng Li

Since Specialization
Citations

This map shows the geographic impact of Zegeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zegeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zegeng Li more than expected).

Fields of papers citing papers by Zegeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zegeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zegeng Li. The network helps show where Zegeng Li may publish in the future.

Co-authorship network of co-authors of Zegeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zegeng Li. A scholar is included among the top collaborators of Zegeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zegeng Li. Zegeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Dengdi, et al.. (2025). Hybrid graph-based radiology report generation. Expert Systems with Applications. 289. 128328–128328.
2.
Zhang, Lu, Shanqing Xu, Hui Wang, et al.. (2025). An exploration of the protective effects of Ginsenoside Rb1 against acute lung injury using network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experiments. International Immunopharmacology. 158. 114822–114822. 1 indexed citations
4.
Chen, Chang, et al.. (2024). A systematic evaluation of quenching, extraction and analysis procedures for metabolomics study of the mechanism of QYSLD intervention in A549 cells. Analytical and Bioanalytical Chemistry. 416(28). 6621–6638. 1 indexed citations
5.
Wu, Huan, et al.. (2024). Rapid identification of chemical constituents and dynamic metabolic profile of Shenqi-Tiaoshen formula in rat plasma based on UPLC-Q-TOF/MSE. Journal of Pharmaceutical and Biomedical Analysis. 241. 115981–115981. 9 indexed citations
6.
Huang, Wanqiu, et al.. (2023). EPHX1 and GSTP1 polymorphisms are associated with COPD risk: a systematic review and meta-analysis. Frontiers in Genetics. 14. 1128985–1128985. 4 indexed citations
8.
Li, Ruijuan, et al.. (2022). The dynamic metabolic profile of Qi-Yu-San-Long decoction in rat urine using UPLC-QTOF-MSE coupled with a post-targeted screening strategy. Journal of Pharmaceutical Analysis. 12(5). 755–765. 9 indexed citations
10.
He, Tiantian, et al.. (2022). The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota. Journal of Translational Medicine. 20(1). 281–281. 36 indexed citations
11.
Gao, Yating, Xinheng Wang, Xiaole Wang, et al.. (2021). Qiyusanlong Formula Induces Autophagy in Non-Small-Cell Lung Cancer Cells and Xenografts through the mTOR Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 2 indexed citations
12.
Wang, Yongqi, Jiaojiao Zhu, Yachao Zhang, et al.. (2020). Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona. Journal of Controlled Release. 320. 1–18. 41 indexed citations
13.
Li, Hai-Yan, Jie Zhu, Caifen Wang, et al.. (2020). Paeonol loaded cyclodextrin metal-organic framework particles for treatment of acute lung injury via inhalation. International Journal of Pharmaceutics. 587. 119649–119649. 59 indexed citations
14.
Wu, Fan, et al.. (2019). [Qibai Pingfei capsule alleviates inflammation and oxidative stress in a chronic obstructive pulmonary disease rat model with syndromes of Qi deficiency and phlegm and blood stasis by regulating the SIRT1/FoxO3a pathway].. PubMed. 35(2). 115–120. 3 indexed citations
15.
Fang, Wei, Qingqing Wu, Jie Wu, et al.. (2019). Metabolic profiling of chronic obstructive pulmonary disease model rats and the interventional effects of HuaTanJiangQi decoction using UHPLC-Q-TOF/MSE. Journal of Pharmaceutical and Biomedical Analysis. 180. 113078–113078. 10 indexed citations
16.
Wu, Huan, Yang Chen, Zegeng Li, & Xianhua Liu. (2018). Untargeted metabolomics profiles delineate metabolic alterations in mouse plasma during lung carcinoma development using UPLC-QTOF/MS in MS E mode. Royal Society Open Science. 5(9). 181143–181143. 33 indexed citations
17.
18.
Yang, Chen, Huan Wu, Xinheng Wang, et al.. (2018). Huaier Granule extract inhibit the proliferation and metastasis of lung cancer cells through down-regulation of MTDH, JAK2/STAT3 and MAPK signaling pathways. Biomedicine & Pharmacotherapy. 101. 311–321. 44 indexed citations
19.
Wang, Chengyang, et al.. (2017). Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway. Cellular Physiology and Biochemistry. 43(2). 743–756. 17 indexed citations
20.
Wang, Chuanbo, et al.. (2016). Effect of Qiyu Sanlong Decoction on Balancing Th1/Th2 Drift in Mice with Lung Cancer. 22(11). 131–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026